Covered recipient · General Payments record
SHANTHAKUMARI PRAVEEN JINNUR
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2022–2024
$347.94
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.84 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $53.46 | 3 |
| Xeris Pharmaceuticals, Inc. | $45.19 | 2 |
| Corcept Therapeutics | $37.83 | 2 |
| Amgen Inc. | $35.63 | 2 |
| UCB, Inc. | $27.36 | 1 |
| Grifols USA, LLC | $22.69 | 1 |
| Ascensia Diabetes Care US Inc. | $19.71 | 1 |
| ABBVIE INC. | $16.83 | 1 |
| Astellas Pharma US Inc | $13.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.83 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103998203 | CMS |
| Amgen Inc. | $13.15 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115767200 | CMS |
| Amgen Inc. | $22.48 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115767208 | CMS |
| Ascensia Diabetes Care Us Inc. | $19.71 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089092999 | CMS |
| Astellas Pharma US Inc | $13.14 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139368947 | CMS |
| Corcept Therapeutics | $19.31 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117762459 | CMS |
| Corcept Therapeutics | $18.52 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117762497 | CMS |
| Grifols USA, LLC | $22.69 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124731277 | CMS |
| Lilly USA, LLC | $15.46 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135346936 | CMS |
| Lilly USA, LLC | $24.13 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135401687 | CMS |
| Lilly USA, LLC | $13.87 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135415831 | CMS |
| UCB, Inc. | $27.36 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143449668 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.12 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613218 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.07 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613220 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.